Biodesix, Inc. provided revenue guidance for the year 2023. For the year, Company expects to generate $50 to $52 million in total revenue in 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +4.51% | +3.73% | -24.46% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.46% | 202M | |
-22.54% | 7.93B | |
+76.82% | 4.54B | |
+8.63% | 2.77B | |
-2.80% | 2.62B | |
-50.41% | 1.99B | |
-17.68% | 1.7B | |
-20.23% | 1.47B | |
+19.61% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2023